Rhône-Poulenc: Difference between revisions
VertyBerty (talk | contribs) No edit summary |
|||
| Line 24: | Line 24: | ||
==History== |
==History== |
||
The company was founded in 1928 through the merger of '''Société des usines chimiques du Rhône''' (Society of Rhône Chemical Factories) from Lyon and [[Poulenc Frères]] (Poulenc Brothers) from Paris founded by Étienne Poulenc, a 19th-century Parisian apothecary and brought to prominence by his second and third sons Émile, father of composer [[Francis Poulenc]], and Camille Poulenc (1864–1942). In 1950, the company synthesized [[chlorpromazine]] which it sold to Smith, Kline & French (today part of [[GlaxoSmithKline]]) who marketed the drug as Thorazine.<ref>{{cite book|author=Whitaker, Robert|title=Mad in America|publisher=Perseus (Basic Books)|year=2002|page=142|isbn=978-0-465-02014-0}}</ref> In 1990, it merged with the pharmaceutical company Rorer to form Rhône-Poulenc Rorer.<ref>{{Cite web |url=http://en.sanofi.com/history/ajax/en_rhone_poulenc.html |title=Rhône Poulenc |access-date=2015-09-08 |archive-date=2015-11-28 |archive-url=https://web.archive.org/web/20151128180338/http://en.sanofi.com/history/ajax/en_rhone_poulenc.html |url-status=dead }}</ref> In January 1999, Rhône-Poulenc merged with [[Hoechst AG]] to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third largest pharmaceutical company in the world. In 2011, Sanofi-Aventis decided to drop the Aventis suffix and change its name to [[Sanofi]]. |
The company was founded in 1928 through the merger of '''Société des usines chimiques du Rhône''' (Society of Rhône Chemical Factories) from Lyon and [[Poulenc Frères]] (Poulenc Brothers) from Paris founded by Étienne Poulenc, a 19th-century Parisian apothecary and brought to prominence by his second and third sons Émile, father of composer [[Francis Poulenc]], and Camille Poulenc (1864–1942). Établissements Poulenc Frères had purchased May & Baker in 1922, the continuing to trade under its original name. |
||
In 1950, the company synthesized [[chlorpromazine]] which it sold to Smith, Kline & French (today part of [[GlaxoSmithKline]]) who marketed the drug as Thorazine.<ref>{{cite book|author=Whitaker, Robert|title=Mad in America|publisher=Perseus (Basic Books)|year=2002|page=142|isbn=978-0-465-02014-0}}</ref> In 1990, it merged with the pharmaceutical company Rorer to form Rhône-Poulenc Rorer.<ref>{{Cite web |url=http://en.sanofi.com/history/ajax/en_rhone_poulenc.html |title=Rhône Poulenc |access-date=2015-09-08 |archive-date=2015-11-28 |archive-url=https://web.archive.org/web/20151128180338/http://en.sanofi.com/history/ajax/en_rhone_poulenc.html |url-status=dead }}</ref> In January 1999, Rhône-Poulenc merged with [[Hoechst AG]] to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third largest pharmaceutical company in the world. In 2011, Sanofi-Aventis decided to drop the Aventis suffix and change its name to [[Sanofi]]. |
|||
The company was bought by Établissements Poulenc Frères (later to become Société des Usines Chimiques Rhône-Poulenc) in 1922,[2] and subsequently moved to Dagenham, Essex, although it continued to trade under the May & Baker name. |
|||
In 1997, its chemicals division was spun off into a separate company named [[Rhodia (company)|Rhodia]] and was later acquired by the [[Solvay (company)|Solvay]] group in 2011. The agricultural chemicals division of Rhône-Poulenc, known as Aventis CropScience after the merger with Hoechst, was sold to the German chemical and pharmaceutical company [[Bayer#Bayer CropScience|Bayer]] in 2002. |
In 1997, its chemicals division was spun off into a separate company named [[Rhodia (company)|Rhodia]] and was later acquired by the [[Solvay (company)|Solvay]] group in 2011. The agricultural chemicals division of Rhône-Poulenc, known as Aventis CropScience after the merger with Hoechst, was sold to the German chemical and pharmaceutical company [[Bayer#Bayer CropScience|Bayer]] in 2002. |
||
Revision as of 18:41, 27 December 2022
 | This article needs additional citations for verification. (August 2022) |
 | |
| Company type | merged with Hoechst AG |
|---|---|
| Industry | Chemicals |
| Founded | 1928 |
| Founder | Étienne Poulenc |
| Products | Chemicals and pharmaceuticals |
Rhône-Poulenc (French pronunciation: [ʁon pulɛ̃k]) was a French chemical and pharmaceutical company founded in 1928. In 1999 it merged with Hoechst AG to form Aventis. As of 2015, the pharmaceutical operations of Rhône-Poulenc are part of Sanofi and the chemicals divisions are part of Solvay group and Bayer Crop Science.
History
The company was founded in 1928 through the merger of Société des usines chimiques du Rhône (Society of Rhône Chemical Factories) from Lyon and Poulenc Frères (Poulenc Brothers) from Paris founded by Étienne Poulenc, a 19th-century Parisian apothecary and brought to prominence by his second and third sons Émile, father of composer Francis Poulenc, and Camille Poulenc (1864–1942). Établissements Poulenc Frères had purchased May & Baker in 1922, the continuing to trade under its original name.
In 1950, the company synthesized chlorpromazine which it sold to Smith, Kline & French (today part of GlaxoSmithKline) who marketed the drug as Thorazine.[1] In 1990, it merged with the pharmaceutical company Rorer to form Rhône-Poulenc Rorer.[2] In January 1999, Rhône-Poulenc merged with Hoechst AG to form Aventis. In 2004, Aventis went on to merge with Sanofi-Synthélabo forming Sanofi-Aventis, the third largest pharmaceutical company in the world. In 2011, Sanofi-Aventis decided to drop the Aventis suffix and change its name to Sanofi.
The company was bought by Établissements Poulenc Frères (later to become Société des Usines Chimiques Rhône-Poulenc) in 1922,[2] and subsequently moved to Dagenham, Essex, although it continued to trade under the May & Baker name.
In 1997, its chemicals division was spun off into a separate company named Rhodia and was later acquired by the Solvay group in 2011. The agricultural chemicals division of Rhône-Poulenc, known as Aventis CropScience after the merger with Hoechst, was sold to the German chemical and pharmaceutical company Bayer in 2002.
In 1997 Rhône-Poulenc came to play a central part in what is claimed to be the worst environmental accident in Sweden's history. Rhône-Poulenc supplied Rhoca-Gil for the building of the Hallandsås tunnel. The chemical leaked into the artesian water, causing great damage to cattle, surrounding nature and workers at the construction site. Rhône-Poulenc was criticised for not pointing out the risks of using the sealant, which contained acrylamide and is considered to be carcinogenic. Criminal charges were brought against the company and In June 2001, the managing director of the former Rhône-Poulenc Sweden was found guilty of breaching the Chemical Products Act, and was to pay 60 day-fines at SEK650 for a total of SEK60 000.[3]
Rhône-Poulenc originally funded the Rhône-Poulenc Prizes, now known as the Royal Society Prizes for Science Books.
Literature
- Chauveau, Sophie. 1999. L'Invention pharmaceutique : la pharmacie française entre l’État et la société au XXe siècle. Le Plessis-Robinson: Sanofi-Synthélabo.
See also
References
- ^ Whitaker, Robert (2002). Mad in America. Perseus (Basic Books). p. 142. ISBN 978-0-465-02014-0.
- ^ "Rhône Poulenc". Archived from the original on 2015-11-28. Retrieved 2015-09-08.
- ^ Mårald (2007), p. 111-117 - See also printed sources
| International | |
|---|---|
| National | |
| Other | |
